Close

Amgen (AMGN) Announces Japanese Approval of Repatha as PCSK9 Inhibitor

January 22, 2016 6:18 AM EST Send to a Friend
Amgen (NASDAQ: AMGN) announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login